Live Breaking News & Updates on Second Line Therapies

Stay updated with breaking news from Second line therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Evolving Landscape of Second-Line Therapies in HCC Management

The Evolving Landscape of Second-Line Therapies in HCC Management
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Tyrosine-kinase-inhibitors , Unresectable-hepatocellular-carcinoma , Evolving-landscape , Second-line-therapies ,

HR+/HER2- Breast Cancer: Inhibiting the PI3K/AKT/mTOR Pathway

Dr Vidal expands on use of PI3K/AKT/mTOR pathway inhibitors following frontline progression, focusing on the PI3K inhibitor alpelisib for patients with PIK3CA mutations, as well as capivasertib, an AKT inhibitor in development. ....

Aditya-bardia , Gregory-vidal , Komal-jhaveri , Hr-her2-breast-cancer , Mutations , Cdk4-6-inhibitors , Second-line-therapies , Endocrine-therapy , Et , Endocrine-resistance , Giredestrant

Potential Approaches to Treatment Switching in HR+/HER2- mBC

Experts share how they approach management of patients with disease progression on first-line endocrine therapy, with a focus on ESR1 mutation testing and identifying who might be suitable for treatment with the oral SERD elacestrant. ....

Komal-jhaveri , Timothy-pluard , Aditya-bardia , Hr-her2-breast-cancer , Mutations , Cdk4-6-inhibitors , Second-line-therapies , Endocrine-therapy , Elacestrant , Esr1 , Emerald-trial

HMP Global Announces Distinguished Faculty Lineup for Inaugural Great Debates & Updates in Women's Oncology


HMP Global Announces Distinguished Faculty Lineup for Inaugural Great Debates & Updates in Women’s Oncology
Share Article
Program features clinical insight from prominent experts in the fields of gynecological and breast cancers; two-day agenda will address hot topics in an interactive, engaging format
“Delivered in the highly popular and uniquely interactive Great Debates & Updates format, this program will offer participants an engaging, educational opportunity,” said Kathleen N. Moore, MD, MS, and Conference Co-Chair of GDU Women’s Oncology.
MALVERN, Pa. (PRWEB)
April 14, 2021
HMP Global, a leading healthcare event and education company, today announced the agenda and faculty lineup for its inaugural Great Debates & Updates in Women’s Oncology, taking place online April 23-24 via the company’s VRTX virtual events platform. The meeting’s faculty is comprised of a distinguishe ....

California , United-states , Arizona , Tennessee , San-francisco , Nikhil-wagle , Carey-anders , Kathleenn-moore , Heatherl-mcarthur , Duke-cancer-institute , Conference-co , University-of-california